| Antabuse | |||
Management of alcohol dependence in selected, highly motivated patients; use in conjunction with supportive and psychotherapeutic treatment.
Not a cure for alcohol dependence; unlikely to have substantive effect when used without proper motivation and supportive therapy.
Administer orally once daily, usually in the morning. If sedation occurs, may administer at bedtime.
Do not administer until patient has abstained from alcohol for ≥12 hours. Never administer without the patient’s knowledge. (See Boxed Warning.)
If adherence is a problem, administer under close supervision, preferably as crushed tablets well mixed with liquid.
Has been prepared and administered as an extemporaneous suspension of 1% disulfiram, ¼% methylcellulose, and 10% Tang® in distilled water. (See Storage under Stability.)
Initially, maximum 500 mg once daily for 1–2 weeks. May reduce dosage if sedation occurs.
Average maintenance dosage: 250 mg daily (range: 125–500 mg daily) until patient is fully recovered socially and a basis for permanent self-control is established. Treatment may be required for months or years.
Maximum 500 mg daily.
No specific dosage recommendations at this time. Use with extreme caution. (See Hepatic Effects and also Concomitant Diseases under Cautions.)
No specific dosage recommendations at this time. Use with extreme caution in patients with acute or chronic nephritis. (See Concomitant Diseases under Cautions.)
Select dosage with caution, usually starting at low end of dosing range, because of age-related decreases in hepatic, renal, and/or cardiac function and of concomitant disease and drug therapy.
![]() |
![]() |
